NS · Pharmaceuticals

Concord Biotech Ltd (CONCORDBIO)

Pharmaceuticals & Biotechnology

Concord Biotech Ltd (CONCORDBIO) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $138.20B, P/E ratio is 52.48, net margin is 27.6%, dividend yield is 0.81%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CONCORDBIO

Market cap

$138.20B

P/E ratio

52.48

Net margin

27.6%

Dividend yield

0.81%

Concord Biotech Ltd (CONCORDBIO) — FAQ

What is Concord Biotech Ltd's market cap?

Concord Biotech Ltd (CONCORDBIO) has a reported market cap of $138.20B (data as of 2026-07-11).

What is CONCORDBIO's P/E ratio?

The price-to-earnings (P/E) ratio for Concord Biotech Ltd (CONCORDBIO) is 52.48 (data as of 2026-07-11).

Does Concord Biotech Ltd pay a dividend?

Concord Biotech Ltd (CONCORDBIO) shows a reported dividend yield of 0.81%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).

What sector is Concord Biotech Ltd in?

Concord Biotech Ltd (CONCORDBIO) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is CONCORDBIO listed on?

CONCORDBIO is listed on NS.

What is Concord Biotech Ltd's net margin?

Concord Biotech Ltd (CONCORDBIO) reports a net margin of 27.6% (data as of 2026-07-11).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)